New research explores the adaptation strategies of polyploid plants, offering insights for cancer treatment and enhancing crop resilience against environmental challenges.
Whole genome duplication (WGD) occurs across all kingdoms of life. While it is most prevalent in plants, it also takes place in certain highly aggressive cancers. Following WGD, a cell acquires additional sets of genomes and is referred to as polyploid.
Most of our major crops are also polyploid, including, wheat, apples, bananas, oats, strawberries, sugar, and brassicas like broccoli and cauliflower. Polyploidy also occurs in some of the most aggressive gliomas (a brain cancer) and is associated with cancer progression. In general, polyploidy has been associated with robustness (as in crops) and adaptation to the environment (as in cancers that metastasize).
Because polyploids have more genomes to manage, the doubling of these genomes can be a weakness, so it is important to understand what factors stabilize young polyploids and how genome-doubled populations evolve.
In this new study, published in Cell Reports, experts from the University of Nottingham’s School of Life Sciences look at how three successfully polyploid plant species evolved to manage the extra DNA and whether they each did this differently or all the same way.
Research Insights from Polyploids
Professor Levi Yant, who led the study said: “Understanding the range of issues that face polyploids may help us to understand why some succeed while others don’t. We see that successful polyploids overcome specific issues with DNA management and we focus on exactly what their ‘natural solutions’ are.
“In our study, we looked at three instances where species have adapted to ‘polyploid life’ and not only survived, but even thrived. Then we looked at whether they used the same molecular solutions to survive. Surprisingly, they did not.”
The researchers found that the clearest signal of rapid adaptation to the polyploid state came from the CENP-E molecule, which is an exact molecule that other groups recently found to be an Achilles heel for polypoid cancers, and is a promising therapeutic target to kill the cancers. The next clearest signal came from ‘meiosis genes’, which Professor Yant notes are turned on in many cancers, whereas they are turned off in nearly all normal cells.
Implications for Cancer Research and Agriculture
“We discovered signals of rapid adaptation to the WGD state in the same molecular networks, and in the case of CENP-E, the exact molecule that is specifically important to polyploid cancers,” continues Professor Yant.
“This WGD gives cancer a short-term advantage over most therapies, but targeting that exact molecule, CENP-E, specifically kills the polyploid cancer. This is a striking example of evolutionary repetition (or convergence) from completely different directions, but to the same adaptive hurdle. We can now take this model that adapts well to polyploidy and that can inform our thinking about certain types of cancer.”
The findings of the study could impact in better understanding of how certain polyploid cancers, such as gliomas (brain cancers) are able to use polyploidy to progress, and what molecules can be targeted as part of any therapy to ‘kill’ the cancer cells.
More broadly, the study is important evidence that shows that mining evolutionary biology for these natural solutions can inform future therapies. Finally, the study also illustrates different ways in the future that we can better engineer our many polyploid crops to be more resilient to certain cataclysmic events – such as climate change.
Reference: “Kinetochore and ionomic adaptation to whole-genome duplication in Cochlearia shows evolutionary convergence in three autopolyploids” by Sian M. Bray, Tuomas Hämälä, Min Zhou, Silvia Busoms, Sina Fischer, Stuart D. Desjardins, Terezie Mandáková, Chris Moore, Thomas C. Mathers, Laura Cowan, Patrick Monnahan, Jordan Koch, Eva M. Wolf, Martin A. Lysak, Filip Kolar, James D. Higgins, Marcus A. Koch and Levi Yant, 7 August 2024, Cell Reports.
DOI: 10.1016/j.celrep.2024.114576
The study was funded by the European Research Council, BBSRC, and the Leverhulme Trust.
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]
